Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 30 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 9675692

    Stabilized formulations containing anti-DLL4 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  2. US 9676840

    Anti-CD100 neutralizing antibodies and methods of using the same

    VACCINEX, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  3. US 9669064

    Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or promoting expression of collagen using Ixora parviflora leaf extract

    China Medical University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  4. US 9663585

    Anti-DCLK1 monoclonal antibodies and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted May 30, 2017 · Expires May 25, 2037

    granted

  5. US 9657102

    Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted

  6. US 9656001

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted May 23, 2017 · Expires May 18, 2037

    granted

  7. US 9657090

    Method of treating alveolar bone loss through the use of anti-sclerostin antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 23, 2017 · Expires May 18, 2037

    granted

  8. US 9657099

    Anti-glucagon antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted

  9. US 9650444

    Anti-PDGFR-beta antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  10. US 9642391

    Anti-regurgitation composition maintaining gut motility

    UNITED PHARMACEUTICALS · Granted May 9, 2017 · Expires May 4, 2037

    granted

  11. US 9636412

    Conjugates of an anti-TNF-alpha antibody

    Nektar Therapeutics · Granted May 2, 2017 · Expires Apr 27, 2037

    granted

  12. US 9624211

    Anti-cancer compounds

    The Board of Regents of the University of Texas System · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  13. US 9624306

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  14. US 9624303

    Single-chain variable fragment anti-CD133 antibodies and uses thereof

    Regents of the University of Minnesota · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  15. US 9616048

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  16. US 9611266

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  17. US 9604973

    Anti-cancer polyketide compounds

    The Regents of the University of California · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  18. US 9605055

    Anti-CD100 antibodies and methods of using the same

    VACCINEX, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  19. US 9598432

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  20. US 9592238

    Anti-ceramide monoclonal antibody 2A2

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  21. US 9580472

    Anti-microbial peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

  22. US 9572873

    Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

    The Regents of the University of California · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted

  23. US 9556232

    Anti-angiogenic molecules, nanostructures and uses thereof

    Northwestern University · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  24. US 9554587

    Anti-regurgitation composition maintaining gut motility

    UNITED PHARMACEUTICALS · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.